Please assess the completion status of the following clinical trial:

Trial Title: Tracking Depression Symptoms With a Health Chatbot

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Provider Subject Cohort: residents and attendings from University of Chicago Medical Center OBGYN and NorthShore Hospital OBGYN clinics.~* Patient Subject Cohort:~  1. Age ≥ 18 years and able to and demonstrate English reading literacy of at least 8th-grade level (REALM-R ≥ 6)~ 2. Postnatal women newly diagnosed or receiving treatment for non-psychotic unipolar depression with a severity-based entry criterion of moderate to severe (EPDS ≥ 12)~ 3. Willing to participate and able to give written informed consent~ 4. Must own a smart phone with a data plan~ 5. Must have a Facebook account and Facebook Messaging app on phone (or willing to create account/download app today)~ 6. Sufficient cognitive ability to provide self-report data on a computer touchscreen/ standard computer with minimal assistance~Exclusion Criteria:~* Provider Subject Cohort: None~* Patient Subject Cohort:~  1. Subjects with documented dysthymia or Axis II diagnoses~ 2. Subjects with self-reported or documented history of: anorexia or bulimia, obsessive compulsive disorder or prior hospitalization for suicidal ideation~ 3. Active suicidality as determined by clinician~ 4. Non-English speakers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Usual Care Group (Type: NO_INTERVENTION): Subjects will undergo screening including Rapid Estimate of Adult Literacy in Medicine (REALM-R) and Edinburgh Postnatal Depression Scale (EPDS) and a few additional questions.~Eligible subjects randomized to usual care will receive monthly reminder phone calls from a research coordinator. Subjects will receive an email with a link to surveys for the purpose of collecting information on depression severity, medication adherence, self-efficacy, side-effect burden, and maternal functioning.~All participants will be asked to participate in a semi-structured debrief interview upon study completion.
- Chabot Care Group (Type: EXPERIMENTAL): Subjects will undergo screening including REALM-R and EPDS and a few additional questions.~Eligible subjects randomized to chatbot care will receive monthly reminder phone calls from a research coordinator. Subjects will receive an email with a link to surveys for the purpose of collecting information on depression severity, medication adherence, self-efficacy, side-effect burden, and maternal functioning.~In addition to the above procedures, eligible subjects randomized to chatbot care will receive weekly messages from the chatbot asking them to complete a depression severity measure and side-effect burden assessments. Within week 1 subjects will receive a check-in call from a study coordinator to answer any questions regarding use of the chatbot.~All participants will be asked to participate in a semi-structured debrief interview upon study completion.
- Provider Subject Cohort (Type: NO_INTERVENTION): 20 provider subjects from each study site will be enrolled to ensure they understand the study and consent to have their patients enrolled in the study

Based on this trial design, predict the completion outcome and termination type (if applicable).